MIR513A1: A Protein Potential Drug Target and Biomarker (G574509)

Target Name: MIR513A1

NCBI ID: G574509

MIR513A1

MIR513A1: A Protein Potential Drug Target and Biomarker

MIR513A1, also known as MIRN513-1, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play a role in cell signaling.

One of the unique features of MIR513A1 is its ability to interact with multiple intracellular signaling pathways, including the TGF-β pathway, the Wnt pathway, and the Hedgehog pathway. This makes MIR513A1 a promising drug target for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

MIR513A1 has also been shown to play a role in several diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that MIR513A1 is overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting MIR513A1 may be an effective way to treat these diseases.

In addition to its role in disease, MIR513A1 has also been shown to be a potential biomarker for several diseases. For example, studies have shown that MIR513A1 is expressed in the brains of individuals with Alzheimer's disease, and that it is associated with poor clinical outcomes in these individuals. This suggests that MIR513A1 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease.

Another potential application of MIR513A1 is its role in drug development. MIR513A1 has been shown to be a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Researchers are currently working to develop small molecules and other compounds that can inhibit MIR513A1's activity and treat these diseases.

In conclusion, MIR513A1 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its ability to interact with multiple intracellular signaling pathways and its association with several diseases make it an attractive target for research and development. Further studies are needed to fully understand the role of MIR513A1 in disease and to develop effective treatments.

Protein Name: MicroRNA 513a-1

The "MIR513A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR513A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets